First-in-Human Trial of DS-2243a in Participants With Advanced Solid Tumors
NCT06644755
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
150
Enrollment
INDUSTRY
Sponsor class
Conditions
Solid Tumors
Sarcoma
Interventions
DRUG:
DS-2243a
Sponsor
Daiichi Sankyo